An AML patient derived monoclonal antibody recognizes a unique CD43 epitope expressed on all myeloid leukemias and shows strong anti-tumor reactivity in vivo

Author(s):
Gillissen, M.A.; Kedde, M.; Jong, G. de; Yasuda, E.; Levie, S.E.; Wagner, K.; Bakker, A.; Hensbergen, P.; Villaudy, J.; Helden, P.M. van; Spits, H.; Hazenberg, M.D.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-12-31
Language
English
Is part of
Clinical Cancer Research (2017), Vol. 23, no. 24, p. 48-48
hdl
1887/115692